Details
Stereochemistry | ACHIRAL |
Molecular Formula | C13H16N2O |
Molecular Weight | 216.2789 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C(OC1=C(C=CC=C1)C2CC2)C3=NCCN3
InChI
InChIKey=YAORIDZYZDUZCM-UHFFFAOYSA-N
InChI=1S/C13H16N2O/c1-2-4-12(11(3-1)10-5-6-10)16-9-13-14-7-8-15-13/h1-4,10H,5-9H2,(H,14,15)
Molecular Formula | C13H16N2O |
Molecular Weight | 216.2789 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Cirazoline is an agonist of alpha1A adrenergic receptor, a partial agonist of alpha1B and alpha1D receptors, and an antagonist of alpha2 adrenergic receptors. Cirazoline was used to study the biologic function of adrenergic receptors. Injection of cirazoline into to the paravenricular hypothalamic nucleus of rats suppressed food and water intake. Cirazoline caused a large renal vasopressor response in rats. Systemic administration of cirazoline impaired spatial working memory in monkeys.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL229 Sources: https://www.ncbi.nlm.nih.gov/pubmed/8564227 |
120.0 nM [Ki] | ||
Target ID: CHEMBL232 Sources: https://www.ncbi.nlm.nih.gov/pubmed/8564227 |
960.0 nM [Ki] | ||
Target ID: CHEMBL223 Sources: https://www.ncbi.nlm.nih.gov/pubmed/8564227 |
660.0 nM [Ki] |
PubMed
Title | Date | PubMed |
---|---|---|
Orthostatic hypotension occurs following alpha 2-adrenoceptor blockade in chronic prazosin-pretreated conscious spontaneously hypertensive rats. | 1992 Aug |
|
Selectivity of the imidazoline alpha-adrenoceptor agonists (oxymetazoline and cirazoline) for human cloned alpha 1-adrenoceptor subtypes. | 1995 Sep |
|
Adrenergic stimulation of lipoprotein lipase gene expression in rat brown adipocytes differentiated in culture: mediation via beta3- and alpha1-adrenergic receptors. | 1997 Feb 1 |
|
The release of noradrenaline in the locus coeruleus and prefrontal cortex studied with dual-probe microdialysis. | 2001 Jul 6 |
|
Noradrenaline release-inhibiting receptors on PC12 cells devoid of alpha(2(-)) and CB(1) receptors: similarities to presynaptic imidazoline and edg receptors. | 2002 Feb |
|
A comparative study of the effects of Cl(-) channel blockers on mesenteric vascular conductance in anaesthetized rat. | 2002 Jul 12 |
|
Stimulation of alpha1-adrenoceptors in the rat medial prefrontal cortex increases the local in vivo 5-hydroxytryptamine release: reversal by antipsychotic drugs. | 2003 Nov |
|
Allosteric modulation of semicarbazide-sensitive amine oxidase activities in vitro by imidazoline receptor ligands. | 2004 Oct |
|
Neurotensin agonists block the prepulse inhibition deficits produced by a 5-HT2A and an alpha1 agonist. | 2004 Sep |
|
Noradrenergic inputs mediate state dependence of auditory responses in the avian song system. | 2004 Sep 1 |
|
alpha1A-adrenoceptors activate glucose uptake in L6 muscle cells through a phospholipase C-, phosphatidylinositol-3 kinase-, and atypical protein kinase C-dependent pathway. | 2005 Feb |
|
Discriminative stimulus properties of the selective and highly potent alpha2-adrenoceptor agonist, S18616, in rats: mediation by the alpha2A subtype, and blockade by the atypical antidepressants, mirtazapine and mianserin. | 2006 Sep |
|
Medial prefrontal cortical alpha1 adrenoreceptor modulation of the nucleus accumbens dopamine response to stress in Long-Evans rats. | 2007 Apr |
|
Presynaptic alpha-adrenoceptors in median preoptic nucleus modulate inhibitory neurotransmission from subfornical organ and organum vasculosum lamina terminalis. | 2007 May |
|
Alpha 1-adrenoceptor agonists protect against stress-induced death of neural progenitor cells. | 2007 Nov 14 |
|
Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prions. | 2008 Apr 23 |
|
The adrenergic receptor subtypes present in frog (Rana esculenta) skin. | 2008 Aug |
|
Enhanced alpha1 adrenergic sensitivity in sensorimotor gating deficits in neonatal ventral hippocampus-lesioned rats. | 2008 Dec |
|
The effects of Cirazoline, an alpha-1 adrenoreceptor agonist, on the firing rates of thermally classified anterior hypothalamic neurons in rat brain slices. | 2008 Feb 8 |
|
Different response of ANP secretion to adrenoceptor stimulation in renal hypertensive rat atria. | 2008 Jul |
|
alpha1-Adrenergic receptors regulate neurogenesis and gliogenesis. | 2009 Aug |
|
alpha(1A)- and alpha(1B)-adrenergic receptors differentially modulate antidepressant-like behavior in the mouse. | 2009 Aug 18 |
|
Human and mouse trace amine-associated receptor 1 have distinct pharmacology towards endogenous monoamines and imidazoline receptor ligands. | 2009 Oct 23 |
|
The selective alpha1 adrenoceptor antagonist HEAT reduces L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. | 2010 Feb |
|
Attenuation of store-operated Ca2+ entry and enhanced expression of TRPC channels in caudal artery smooth muscle from Type 2 diabetic Goto-Kakizaki rats. | 2010 Jul |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:21:19 GMT 2023
by
admin
on
Sat Dec 16 16:21:19 GMT 2023
|
Record UNII |
QK318GVY3Y
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29709
Created by
admin on Sat Dec 16 16:21:20 GMT 2023 , Edited by admin on Sat Dec 16 16:21:20 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL13852
Created by
admin on Sat Dec 16 16:21:20 GMT 2023 , Edited by admin on Sat Dec 16 16:21:20 GMT 2023
|
PRIMARY | |||
|
SUB07478MIG
Created by
admin on Sat Dec 16 16:21:20 GMT 2023 , Edited by admin on Sat Dec 16 16:21:20 GMT 2023
|
PRIMARY | |||
|
59939-16-1
Created by
admin on Sat Dec 16 16:21:20 GMT 2023 , Edited by admin on Sat Dec 16 16:21:20 GMT 2023
|
PRIMARY | |||
|
DB09202
Created by
admin on Sat Dec 16 16:21:20 GMT 2023 , Edited by admin on Sat Dec 16 16:21:20 GMT 2023
|
PRIMARY | |||
|
C014282
Created by
admin on Sat Dec 16 16:21:20 GMT 2023 , Edited by admin on Sat Dec 16 16:21:20 GMT 2023
|
PRIMARY | |||
|
C77294
Created by
admin on Sat Dec 16 16:21:20 GMT 2023 , Edited by admin on Sat Dec 16 16:21:20 GMT 2023
|
PRIMARY | |||
|
DTXSID4045131
Created by
admin on Sat Dec 16 16:21:20 GMT 2023 , Edited by admin on Sat Dec 16 16:21:20 GMT 2023
|
PRIMARY | |||
|
2765
Created by
admin on Sat Dec 16 16:21:20 GMT 2023 , Edited by admin on Sat Dec 16 16:21:20 GMT 2023
|
PRIMARY | |||
|
CIRAZOLINE
Created by
admin on Sat Dec 16 16:21:20 GMT 2023 , Edited by admin on Sat Dec 16 16:21:20 GMT 2023
|
PRIMARY | |||
|
4221
Created by
admin on Sat Dec 16 16:21:20 GMT 2023 , Edited by admin on Sat Dec 16 16:21:20 GMT 2023
|
PRIMARY | |||
|
QK318GVY3Y
Created by
admin on Sat Dec 16 16:21:20 GMT 2023 , Edited by admin on Sat Dec 16 16:21:20 GMT 2023
|
PRIMARY | |||
|
100000081544
Created by
admin on Sat Dec 16 16:21:20 GMT 2023 , Edited by admin on Sat Dec 16 16:21:20 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
Ki
|
||
|
TARGET -> AGONIST |
Ki
|
||
|
TARGET -> AGONIST | |||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|